{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:30:09Z","timestamp":1790652609675,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"German Federal Ministry of Education and Research"},{"DOI":"10.13039\/501100001713","name":"European & Developing Countries Clinical Trials Partnership","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010336","name":"Fundaci\u00f3 Privada Daniel Bravo Andreu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["CEX2023-0001290-S"],"award-info":[{"award-number":["CEX2023-0001290-S"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["RYC 2020-029886-I\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["RYC 2020-029886-I\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015439","name":"Centres de Recerca de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015439","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04607-9","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:33:36Z","timestamp":1768368816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Determinants of long-term SARS-CoV-2 immune responses in asymptomatic-to-moderate COVID-19 patients in sub-Saharan Africa"],"prefix":"10.1186","volume":"24","author":[{"given":"V\u00edctor L.","family":"de Rioja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odin","family":"Goovaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Amuasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony Afum-Adjei","family":"Awuah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Kahusu","family":"Mwan-za-k\u2019a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Placide","family":"Mbala-Kingebeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritha Nyembu","family":"Kibambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Tshitamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirac","family":"Kazadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendemagegn Embiale","family":"Yeshaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dereje Bedane","family":"Hunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mezgebu","family":"Asres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fitsumbrhan","family":"Tajebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia Mutisse","family":"Massinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia","family":"Maphossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumou Maiga","family":"Ascofare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Monnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila Ibnou Zekri","family":"Lassout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ANTICOV-IMMUNO Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Doba\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Fern\u00e1ndez-Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fuente-Soro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"L\u00f3pez-Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00eddac","family":"Maci\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba Madrero","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Naniche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Salvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Santano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"De Hondt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selien","family":"Oostvogels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laur\u00e8ne","family":"Peckeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"van Griensven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"van Hul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin","family":"Agbogbatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim","family":"Alani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebenezer","family":"Boham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Bonney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Gmanyami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"Hasford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Duah","family":"Kwaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Obirikorang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Owusu","family":"Boakye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomie","family":"Bayoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobo","family":"Bazola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elys\u00e9e","family":"Matungulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ange","family":"Mubiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth Muyamuna","family":"Mulombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Shamamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Tshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Mbunsu-Kizito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabue","family":"Mulangu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieudonn\u00e9 Mumba","family":"Ngoyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Nkuba-Ndaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Kabongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junior","family":"Matangila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taty","family":"Sakobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Lekue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JP","family":"Lubanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yared","family":"Getachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getnet","family":"Mesfin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Begna","family":"Tulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadelo","family":"Wondmagegn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aynishet","family":"Adane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailemaryam","family":"Alemu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endalkachew Belayneh","family":"Melese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Nhalungo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Habermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Lamshoeft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel Diyi","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Louvion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Monnerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eltahir","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatim","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brima","family":"Younis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid S.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Colombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Carolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Adriaensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Moncunill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"4607_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-008793","volume":"7","author":"HC Lewis","year":"2022","unstructured":"Lewis HC, Ware H, Whelan M, Subissi L, Li Z, Ma X, et al. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021. BMJ Glob Health. 2022;7:e008793. https:\/\/doi.org\/10.1136\/bmjgh-2022-008793.","journal-title":"BMJ Glob Health"},{"key":"4607_CR2","unstructured":"World Health Organization African Region. Over two-thirds of Africans exposed to virus which causes COVID-19: WHO study. https:\/\/www.afro.who.int\/news\/over-two-thirds-africans-exposed-virus-which-causes-covid-19-who-study. 2022."},{"key":"4607_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijid.2020.10.038","volume":"102","author":"Y Lawal","year":"2021","unstructured":"Lawal Y. Africa\u2019s low COVID-19 mortality rate: a paradox? Int J Infect Dis. 2021;102:118\u201322. https:\/\/doi.org\/10.1016\/j.ijid.2020.10.038.","journal-title":"Int J Infect Dis"},{"key":"4607_CR4","doi-asserted-by":"publisher","first-page":"E222","DOI":"10.1097\/INF.0000000000003916","volume":"42","author":"OK Manna","year":"2023","unstructured":"Manna OK, Costa Clemens SA, Clemens R. Investigating the possible reasons for the low reported morbidity and mortality of COVID-19 in African countries: an integrative review. Pediatr Infect Dis J. 2023;42:E222-8. https:\/\/doi.org\/10.1097\/INF.0000000000003916.","journal-title":"Pediatr Infect Dis J"},{"key":"4607_CR5","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1016\/S1473-3099(25)00071-4","volume":"25","author":"P Bejon","year":"2025","unstructured":"Bejon P, Agweyu A, Ochola-Oyier LI, Hamaluba M, Kamuya D, Kinyanjui S, et al. Rethinking the evidence on COVID-19 in Africa. Lancet Infect Dis. 2025;25:e463\u201371. https:\/\/doi.org\/10.1016\/S1473-3099(25)00071-4.","journal-title":"Lancet Infect Dis"},{"key":"4607_CR6","doi-asserted-by":"publisher","unstructured":"Doshi RH, Nsasiirwe S, Dahlke M, Atagbaza A, Oniovo EA, Tatsinkou AB, et al. Morbidity and mortality weekly report COVID-19 vaccination coverage-World Health Organization African Region, 2021\u20132023. Centers for Disease Control and Prevention | MMWR. 2024;73:307\u201311. https:\/\/doi.org\/10.15585\/mmwr.mm7314a3.","DOI":"10.15585\/mmwr.mm7314a3"},{"key":"4607_CR7","unstructured":"Mathieu E, Ritchie H, Rod\u00e9s-Guirao L, Appel C, Gavrilov D, Giattino C, et al. Coronavirus (COVID-19) Cases. https:\/\/ourworldindata.org\/covid-cases. 2020."},{"key":"4607_CR8","unstructured":"\u201cAfrica CDC.\u201d Africa CDC COVID-19 Dashboard. https:\/\/africacdc.org\/covid-19\/. 2023."},{"key":"4607_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1126\/science.abe1916","volume":"371","author":"S Uyoga","year":"2021","unstructured":"Uyoga S, Adetifa IMO, Karanja HK, Nyagwange J, Tuju J, Wanjiku P, et al. Seroprevalence of anti\u2013SARS-CoV-2 IgG antibodies in Kenyan blood donors. Science. 2021;371:79\u201382. https:\/\/doi.org\/10.1126\/science.abe1916.","journal-title":"Science"},{"key":"4607_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13040336","volume":"13","author":"L Kato","year":"2025","unstructured":"Kato L, Sembera J, Oluka GK, Katende JS, Bemanzi J, Ankunda V, et al. Geographical differences in SARS-CoV-2 antibody response dynamics and neutralisation profiles to mild COVID-19: lessons from a UK\u2013Uganda comparison. Vaccines. 2025;13:336. https:\/\/doi.org\/10.3390\/vaccines13040336.","journal-title":"Vaccines"},{"key":"4607_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.07.005","volume":"6","author":"M Mbow","year":"2025","unstructured":"Mbow M, Hoving D, Cisse M, Diallo I, Honkpehedji YJ, Huisman W, et al. Immune responses to SARS-CoV-2 in sub-Saharan Africa and western Europe: a retrospective, population-based, cross-sectional study. Lancet Microbe. 2025;6:100942. https:\/\/doi.org\/10.1016\/j.lanmic.2024.07.005.","journal-title":"Lancet Microbe"},{"key":"4607_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12040363","author":"DJ Ny Mioramalala","year":"2024","unstructured":"Ny Mioramalala DJ, Ratovoson R, Tagnouokam-Ngoupo PA, Abessolo Abessolo H, Mindimi Nkodo JM, Bouting Mayaka G, et al. SARS-CoV-2 neutralizing antibodies in three African countries following multiple distinct immune challenges. Vaccines. 2024. https:\/\/doi.org\/10.3390\/vaccines12040363.","journal-title":"Vaccines"},{"key":"4607_CR13","unstructured":"ANTICOV Consortium. Resources ANTICOV Trial. https:\/\/anticov.org\/resources\/. 2024."},{"key":"4607_CR14","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1056\/NEJMoa2115869","volume":"386","author":"G Reis","year":"2022","unstructured":"Reis G, Silva EASM, Silva DCM, Thabane L, Milagres AC, Ferreira TS, et al. Effect of early treatment with ivermectin among patients with COVID-19. N Engl J Med. 2022;386:1721\u201331. https:\/\/doi.org\/10.1056\/NEJMoa2115869.","journal-title":"N Engl J Med"},{"key":"4607_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10163545","volume":"10","author":"J-Y Song","year":"2021","unstructured":"Song J-Y, Yoon J-G, Seo Y-B, Lee J, Eom J-S, Lee J-S, et al. Ciclesonide inhaler treatment for mild-to-moderate COVID-19: a randomized, open-label, phase 2 trial. J Clin Med. 2021;10:3545. https:\/\/doi.org\/10.3390\/jcm10163545.","journal-title":"J Clin Med"},{"key":"4607_CR16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0140-6736(21)01744-X","volume":"398","author":"L-M Yu","year":"2021","unstructured":"Yu L-M, Bafadhel M, Dorward J, Hayward G, Saville BR, Gbinigie O, et al. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021;398:843\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)01744-X.","journal-title":"Lancet"},{"key":"4607_CR17","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(20)32013-4","volume":"396","author":"PW Horby","year":"2020","unstructured":"Horby PW, Mafham M, Bell JL, Linsell L, Staplin N, Emberson J, et al. Lopinavir\u2013ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2020;396:1345\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(20)32013-4.","journal-title":"Lancet"},{"key":"4607_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2023184","volume":"384","author":"WHO Solidarity Trial Consortium","year":"2021","unstructured":"WHO Solidarity Trial Consortium. Repurposed antiviral drugs for COVID-19\u2014interim WHO solidarity trial results. N Engl J Med. 2021;384:497\u2013511. https:\/\/doi.org\/10.1056\/NEJMoa2023184.","journal-title":"N Engl J Med"},{"key":"4607_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-00943-2","volume":"5","author":"C Mart\u00edn P\u00e9rez","year":"2025","unstructured":"Mart\u00edn P\u00e9rez C, Ram\u00edrez-Morros A, Jim\u00e9nez A, Vidal M, Pradenas E, Barrios D, et al. Determinants of antibody levels and protection against omicron BQ.1\/XBB breakthrough infection. Commun Med. 2025;5:243. https:\/\/doi.org\/10.1038\/s43856-025-00943-2.","journal-title":"Commun Med"},{"key":"4607_CR20","doi-asserted-by":"publisher","unstructured":"Doba\u00f1o C, Alonso S, Fern\u00e1ndez de Sevilla M, Vidal M, Jim\u00e9nez A, Pons Tomas G, et al. Antibody conversion rates to SARS-CoV-2 in saliva from children attending summer schools in Barcelona, Spain. BMC Med. 2021;19:309. https:\/\/doi.org\/10.1186\/s12916-021-02184-1.","DOI":"10.1186\/s12916-021-02184-1"},{"key":"4607_CR21","doi-asserted-by":"publisher","first-page":"e2255978","DOI":"10.1001\/jamanetworkopen.2022.55978","volume":"6","author":"J Briggs","year":"2023","unstructured":"Briggs J, Takahashi S, Nayebare P, Cuu G, Rek J, Zedi M, et al. Seroprevalence of antibodies to SARS-CoV-2 in rural households in Eastern Uganda, 2020\u20132022. JAMA Netw Open. 2023;6:e2255978\u2013e2255978. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.55978.","journal-title":"JAMA Netw Open"},{"key":"4607_CR22","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","volume":"26","author":"Q-X Long","year":"2020","unstructured":"Long Q-X, Liu B-Z, Deng H-J, Wu G-C, Deng K, Chen Y-K, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26:845\u20138. https:\/\/doi.org\/10.1038\/s41591-020-0897-1.","journal-title":"Nat Med"},{"key":"4607_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.trsl.2021.02.006","volume":"232","author":"C Doba\u00f1o","year":"2021","unstructured":"Doba\u00f1o C, Santano R, Jim\u00e9nez A, Vidal M, Chi J, Rodrigo Melero N, et al. Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies. Transl Res. 2021;232:60\u201374. https:\/\/doi.org\/10.1016\/j.trsl.2021.02.006.","journal-title":"Transl Res"},{"key":"4607_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101902","volume":"3","author":"LM Weskamm","year":"2022","unstructured":"Weskamm LM, Dahlke C, Addo MM. Flow cytometric protocol to characterize human memory B cells directed against SARS-CoV-2 spike protein antigens. STAR Protoc. 2022;3:101902. https:\/\/doi.org\/10.1016\/j.xpro.2022.101902.","journal-title":"STAR Protoc"},{"key":"4607_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2024.105423","volume":"27","author":"R Rubio","year":"2025","unstructured":"Rubio R, Maci\u00e0 D, Barrios D, Vidal M, Jim\u00e9nez A, Molinos-Albert LM, et al. High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination. Microbes Infect. 2025;27:105423. https:\/\/doi.org\/10.1016\/j.micinf.2024.105423.","journal-title":"Microbes Infect"},{"key":"4607_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100354","volume":"2","author":"KW Cohen","year":"2021","unstructured":"Cohen KW, Linderman SL, Moodie Z, Czartoski J, Lai L, Mantus G, et al. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Rep Med. 2021;2:100354. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100354.","journal-title":"Cell Rep Med"},{"key":"4607_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf4063","volume":"371","author":"JM Dan","year":"2021","unstructured":"Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, Faliti CE, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371:eabf4063. https:\/\/doi.org\/10.1126\/science.abf4063.","journal-title":"Science"},{"key":"4607_CR28","doi-asserted-by":"publisher","first-page":"e724","DOI":"10.1016\/S2214-109X(21)00092-9","volume":"9","author":"E Usuf","year":"2021","unstructured":"Usuf E, Roca A. Seroprevalence surveys in sub-Saharan Africa: what do they tell us? Lancet Glob Health. 2021;9:e724\u20135. https:\/\/doi.org\/10.1016\/S2214-109X(21)00092-9.","journal-title":"Lancet Glob Health"},{"key":"4607_CR29","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/cid\/ciac797","volume":"76","author":"NE Kogan","year":"2023","unstructured":"Kogan NE, Gantt S, Swerdlow D, Viboud C, Semakula M, Lipsitch M, et al. Leveraging serosurveillance and postmortem surveillance to quantify the impact of coronavirus disease 2019 in Africa. Clin Infect Dis. 2023;76:424\u201332. https:\/\/doi.org\/10.1093\/cid\/ciac797.","journal-title":"Clin Infect Dis"},{"key":"4607_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045425","volume":"11","author":"R Grant","year":"2021","unstructured":"Grant R, Dub T, Andrianou X, Nohynek H, Wilder-Smith A, Pezzotti P, et al. SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review. BMJ Open. 2021;11:e045425. https:\/\/doi.org\/10.1136\/bmjopen-2020-045425.","journal-title":"BMJ Open"},{"key":"4607_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29713","volume":"96","author":"R Aguilar","year":"2024","unstructured":"Aguilar R, Jim\u00e9nez A, Santano R, Vidal M, Maiga-Ascofare O, Strauss R, et al. Malaria and other infections induce polyreactive antibodies that impact SARS-CoV-2 seropositivity estimations in endemic settings. J Med Virol. 2024;96:e29713. https:\/\/doi.org\/10.1002\/jmv.29713.","journal-title":"J Med Virol"},{"key":"4607_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02032-2","volume":"19","author":"C Doba\u00f1o","year":"2021","unstructured":"Doba\u00f1o C, Ram\u00edrez-Morros A, Alonso S, Vidal-Alaball J, Ruiz-Olalla G, Vidal M, et al. Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19. BMC Med. 2021;19:155. https:\/\/doi.org\/10.1186\/s12916-021-02032-2.","journal-title":"BMC Med"},{"key":"4607_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02570-3","author":"C Doba\u00f1o","year":"2022","unstructured":"Doba\u00f1o C, Ram\u00edrez-Morros A, Alonso S, Rubio R, Ruiz-Olalla G, Vidal-Alaball J, et al. Sustained seropositivity up to 20.5 months after COVID-19. BMC Med. 2022. https:\/\/doi.org\/10.1186\/s12916-022-02570-3.","journal-title":"BMC Med"},{"key":"4607_CR34","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1038\/s41467-021-24979-9","volume":"12","author":"N Ortega","year":"2021","unstructured":"Ortega N, Ribes M, Vidal M, Rubio R, Aguilar R, Williams S, et al. Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses. Nat Commun. 2021;12:4740. https:\/\/doi.org\/10.1038\/s41467-021-24979-9.","journal-title":"Nat Commun"},{"key":"4607_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103561","volume":"71","author":"F Gallais","year":"2021","unstructured":"Gallais F, Gantner P, Bruel T, Velay A, Planas D, Wendling MJ, et al. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection. EBioMedicine. 2021;71:103561. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103561.","journal-title":"EBioMedicine"},{"key":"4607_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1261","volume":"10","author":"AL Whitcombe","year":"2021","unstructured":"Whitcombe AL, McGregor R, Craigie A, James A, Charlewood R, Lorenz N, et al. Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand. Clin Transl Immunol. 2021;10:e1261. https:\/\/doi.org\/10.1002\/cti2.1261.","journal-title":"Clin Transl Immunol"},{"key":"4607_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0288557","volume":"18","author":"H Amellal","year":"2023","unstructured":"Amellal H, Assaid N, Charoute H. Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: a prospective longitudinal study. PLoS ONE. 2023;18:1\u201322. https:\/\/doi.org\/10.1371\/journal.pone.0288557.","journal-title":"PLoS ONE"},{"key":"4607_CR38","doi-asserted-by":"publisher","first-page":"784.e1","DOI":"10.1016\/j.cmi.2021.01.005","volume":"27","author":"AG L\u2019Huillier","year":"2021","unstructured":"L\u2019Huillier AG, Meyer B, Andrey DO, Arm-Vernez I, Baggio S, Didierlaurent A, et al. Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study. Clin Microbiol Infect. 2021;27:784.e1-784.e8. https:\/\/doi.org\/10.1016\/j.cmi.2021.01.005.","journal-title":"Clin Microbiol Infect"},{"key":"4607_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115498","volume":"44","author":"LM Molinos-Albert","year":"2025","unstructured":"Molinos-Albert LM, Rubio R, Mart\u00edn-P\u00e9rez C, Pradenas E, Torres C, Jim\u00e9nez A, et al. Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic. Cell Rep. 2025;44:115498. https:\/\/doi.org\/10.1016\/j.celrep.2025.115498.","journal-title":"Cell Rep"},{"key":"4607_CR40","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine T, Perez-Potti A, Rivera-Ballesteros O, Str\u00e5lin K, Gorin JB, Olsson A, et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell. 2020;183:158-168.e14. https:\/\/doi.org\/10.1016\/j.cell.2020.08.017.","journal-title":"Cell"},{"key":"4607_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1285","volume":"10","author":"M Steenhuis","year":"2021","unstructured":"Steenhuis M, van Mierlo G, Derksen NIL, Ooijevaar-de Heer P, Kruithof S, Loeff FL, et al. Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors. Clin Transl Immunology. 2021;10:e1285. https:\/\/doi.org\/10.1002\/cti2.1285.","journal-title":"Clin Transl Immunology"},{"key":"4607_CR42","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/cid\/ciab607","volume":"74","author":"L Grandjean","year":"2022","unstructured":"Grandjean L, Saso A, Torres Ortiz A, Lam T, Hatcher J, Thistlethwayte R, et al. Long-term persistence of spike protein antibody and predictive modeling of antibody dynamics after infection with severe acute respiratory syndrome coronavirus 2. Clin Infect Dis. 2022;74:1220\u20139. https:\/\/doi.org\/10.1093\/cid\/ciab607.","journal-title":"Clin Infect Dis"},{"key":"4607_CR43","doi-asserted-by":"publisher","first-page":"15447","DOI":"10.1038\/s41598-022-19581-y","volume":"12","author":"JS Takeuchi","year":"2022","unstructured":"Takeuchi JS, Fukunaga A, Yamamoto S, Tanaka A, Matsuda K, Kimura M, et al. SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2: a 9 months longitudinal study. Sci Rep. 2022;12:15447. https:\/\/doi.org\/10.1038\/s41598-022-19581-y.","journal-title":"Sci Rep"},{"key":"4607_CR44","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.4049\/jimmunol.2000717","volume":"205","author":"R Varnait\u0117","year":"2020","unstructured":"Varnait\u0117 R, Garc\u00eda M, Glans H, Maleki KT, Sandberg JT, Tynell J, et al. Expansion of SARS-CoV-2\u2013specific antibody-secreting cells and generation of neutralizing antibodies in hospitalized COVID-19 patients. J Immunol. 2020;205:2437\u201346. https:\/\/doi.org\/10.4049\/jimmunol.2000717.","journal-title":"J Immunol"},{"key":"4607_CR45","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.1038\/s41467-022-33792-x","volume":"13","author":"A Abdullahi","year":"2022","unstructured":"Abdullahi A, Oladele D, Owusu M, Kemp SA, Ayorinde J, Salako A, et al. SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa. Nat Commun. 2022;13:6131. https:\/\/doi.org\/10.1038\/s41467-022-33792-x.","journal-title":"Nat Commun"},{"key":"4607_CR46","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.19414.2","volume":"8","author":"J Kimotho","year":"2024","unstructured":"Kimotho J, Sein Y, Sayed S, Shah R, Mwai K, Saleh M, et al. Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study. Wellcome Open Res. 2024;8:350. https:\/\/doi.org\/10.12688\/wellcomeopenres.19414.2.","journal-title":"Wellcome Open Res"},{"key":"4607_CR47","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1038\/s41591-024-03131-2","volume":"30","author":"K Sun","year":"2024","unstructured":"Sun K, Bhiman JN, Tempia S, Kleynhans J, Madzorera VS, Mkhize Q, et al. SARS-CoV-2 correlates of protection from infection against variants of concern. Nat Med. 2024;30:2805\u201312. https:\/\/doi.org\/10.1038\/s41591-024-03131-2.","journal-title":"Nat Med"},{"key":"4607_CR48","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jinf.2022.09.004","volume":"85","author":"A Atti","year":"2022","unstructured":"Atti A, Insalata F, Carr EJ, Otter AD, Castillo-Olivares J, Wu M, et al. Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: a nested case-control within the SIREN study. J Infect. 2022;85:545\u201356. https:\/\/doi.org\/10.1016\/j.jinf.2022.09.004.","journal-title":"J Infect"},{"key":"4607_CR49","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ijid.2022.01.041","volume":"116","author":"BL H\u00f8nge","year":"2022","unstructured":"H\u00f8nge BL, Hindhede L, Kaspersen KA, Harritsh\u00f8j LH, Mikkelsen S, Holm DK, et al. Long-term detection of SARS-CoV-2 antibodies after infection and risk of re-infection. Int J Infect Dis. 2022;116:289\u201392. https:\/\/doi.org\/10.1016\/j.ijid.2022.01.041.","journal-title":"Int J Infect Dis"},{"key":"4607_CR50","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3390\/v14081603","volume":"14","author":"AV Kudriavtsev","year":"2022","unstructured":"Kudriavtsev AV, Vakhrusheva AV, Novoseletsky VN, Bozdaganyan ME, Shaitan KV, Kirpichnikov MP, et al. Immune escape associated with RBD omicron mutations and SARS-CoV-2 evolution dynamics. Viruses. 2022;14:1603. https:\/\/doi.org\/10.3390\/v14081603.","journal-title":"Viruses"},{"key":"4607_CR51","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41591-021-01318-5","volume":"27","author":"D Planas","year":"2021","unstructured":"Planas D, Bruel T, Grzelak L, Guivel-Benhassine F, Staropoli I, Porrot F, et al. Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies. Nat Med. 2021;27:917\u201324. https:\/\/doi.org\/10.1038\/s41591-021-01318-5.","journal-title":"Nat Med"},{"key":"4607_CR52","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41579-022-00841-7","volume":"21","author":"AM Carabelli","year":"2023","unstructured":"Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J, de Silva TI, et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol. 2023;21:162\u201377. https:\/\/doi.org\/10.1038\/s41579-022-00841-7.","journal-title":"Nat Rev Microbiol"},{"key":"4607_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.744242","volume":"12","author":"F Lou","year":"2021","unstructured":"Lou F, Li M, Pang Z, Jiang L, Guan L, Tian L, et al. Understanding the secret of SARS-CoV-2 variants of concern\/interest and immune escape. Front Immunol. 2021;12:744242. https:\/\/doi.org\/10.3389\/fimmu.2021.744242.","journal-title":"Front Immunol"},{"key":"4607_CR54","doi-asserted-by":"publisher","unstructured":"Noori M, Nejadghaderi SA, Arshi S, Carson-Chahhoud K, Ansarin K, Kolahi A-A, et al. Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: a systematic review of in vitro studies. Rev Med Virol. 2022;32:e2277. https:\/\/doi.org\/10.1002\/rmv.2277.","DOI":"10.1002\/rmv.2277"},{"key":"4607_CR55","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","volume":"599","author":"P Mlcochova","year":"2021","unstructured":"Mlcochova P, Kemp SA, Dhar MS, Papa G, Meng B, Ferreira IATM, et al. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature. 2021;599:114\u20139. https:\/\/doi.org\/10.1038\/s41586-021-03944-y.","journal-title":"Nature"},{"key":"4607_CR56","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01514-22","volume":"10","author":"B Lubinski","year":"2022","unstructured":"Lubinski B, Frazier LE, Phan MVT, Bugembe DL, Cunningham JL, Tang T, et al. Spike protein cleavage-activation in the context of the SARS-CoV-2 P681R mutation: an analysis from its first appearance in lineage A.23.1 identified in Uganda. Microbiol Spectr. 2022;10: e0151422. https:\/\/doi.org\/10.1128\/spectrum.01514-22.","journal-title":"Microbiol Spectr."},{"key":"4607_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13020143","volume":"13","author":"GK Oluka","year":"2025","unstructured":"Oluka GK, Sembera J, Katende JS, Ankunda V, Kato L, Kurshan A, et al. Long-term immune consequences of initial SARS-CoV-2 A.23.1 exposure: a longitudinal study of antibody responses and cross-neutralization in a Ugandan cohort. Vaccines. 2025;13:143. https:\/\/doi.org\/10.3390\/vaccines13020143.","journal-title":"Vaccines"},{"key":"4607_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103467","volume":"24","author":"A Kuzmina","year":"2021","unstructured":"Kuzmina A, Wattad S, Khalaila Y, Ottolenghi A, Rosental B, Engel S, et al. SARS CoV-2 Delta variant exhibits enhanced infectivity and a minor decrease in neutralization sensitivity to convalescent or post-vaccination sera. iScience. 2021;24:103467. https:\/\/doi.org\/10.1016\/j.isci.2021.103467.","journal-title":"iScience"},{"key":"4607_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/v13122405","volume":"13","author":"CA Sariol","year":"2021","unstructured":"Sariol CA, Serrano\u2010collazo C, Ortiz EJ, Pantoja P, Cruz L, Arana T, et al. Limited impact of delta variant\u2019s mutations on the effectiveness of neutralization conferred by natural infection or COVID\u201019 vaccines in a latino population. Viruses. 2021;13:2405. https:\/\/doi.org\/10.3390\/v13122405.","journal-title":"Viruses"},{"key":"4607_CR60","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01648-20","volume":"95","author":"S Matsuyama","year":"2020","unstructured":"Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, et al. The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells. J Virol. 2020;95:e01648. https:\/\/doi.org\/10.1128\/jvi.01648-20.","journal-title":"J Virol"},{"key":"4607_CR61","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41429-021-00491-6","volume":"75","author":"AK Zaidi","year":"2022","unstructured":"Zaidi AK, Dehgani-Mobaraki P. The mechanisms of action of ivermectin against SARS-CoV-2\u2014an extensive review. J Antibiot. 2022;75:60\u201371. https:\/\/doi.org\/10.1038\/s41429-021-00491-6.","journal-title":"J Antibiot"},{"key":"4607_CR62","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.cell.2022.01.018","volume":"185","author":"K R\u00f6ltgen","year":"2022","unstructured":"R\u00f6ltgen K, Nielsen SCA, Silva O, Younes SF, Zaslavsky M, Costales C, et al. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell. 2022;185:1025-1040.e14. https:\/\/doi.org\/10.1016\/j.cell.2022.01.018.","journal-title":"Cell"},{"key":"4607_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103805","volume":"75","author":"G Moncunill","year":"2022","unstructured":"Moncunill G, Aguilar R, Ribes M, Ortega N, Rubio R, Salmer G, et al. Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and na\u00efve healthcare workers. EBioMedicine. 2022;75:103805. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103805.","journal-title":"EBioMedicine"},{"key":"4607_CR64","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12916-024-03304-3","volume":"22","author":"C Mart\u00edn P\u00e9rez","year":"2024","unstructured":"Mart\u00edn P\u00e9rez C, Aguilar R, Jim\u00e9nez A, Salmer\u00f3n G, Canyelles M, Rubio R, et al. Correlates of protection and determinants of SARS-CoV-2 breakthrough infections 1 year after third dose vaccination. BMC Med. 2024;22:103. https:\/\/doi.org\/10.1186\/s12916-024-03304-3.","journal-title":"BMC Med"},{"key":"4607_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101655","volume":"53","author":"HJ Zar","year":"2022","unstructured":"Zar HJ, MacGinty R, Workman L, Botha M, Johnson M, Hunt A, et al. Natural and hybrid immunity following four COVID-19 waves: a prospective cohort study of mothers in South Africa. EClinicalMedicine. 2022;53:101655. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101655.","journal-title":"EClinicalMedicine"},{"key":"4607_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106473","volume":"90","author":"C Mart\u00edn P\u00e9rez","year":"2025","unstructured":"Mart\u00edn P\u00e9rez C, Ruiz-Rius S, Ram\u00edrez-Morros A, Vidal M, Opi DH, Santamaria P, et al. Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections. J Infect. 2025;90:106473. https:\/\/doi.org\/10.1016\/j.jinf.2025.106473.","journal-title":"J Infect"},{"key":"4607_CR67","doi-asserted-by":"publisher","first-page":"1596065","DOI":"10.3389\/fimmu.2025.1596065","volume":"16","author":"Q Luo","year":"2025","unstructured":"Luo Q, Song Q, Li Y, Zong K, Liu T, He J, et al. Reduced immune response to SARS-CoV-2 infection in the elderly after 6 months. Front Immunol. 2025;16:1596065. https:\/\/doi.org\/10.3389\/fimmu.2025.1596065.","journal-title":"Front Immunol"},{"key":"4607_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.942796","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Dong C, Han Y, Gu Z, Sun C. Immunosenescence, aging and successful aging. Front Immunol. 2022;13:942796. https:\/\/doi.org\/10.3389\/fimmu.2022.942796.","journal-title":"Front Immunol"},{"key":"4607_CR69","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.4302","volume":"4","author":"HS Yang","year":"2021","unstructured":"Yang HS, Costa V, Racine-Brzostek SE, Acker KP, Yee J, Chen Z, et al. Association of age with SARS-CoV-2 antibody response. JAMA Netw Open. 2021;4:e214302. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.4302.","journal-title":"JAMA Netw Open"},{"key":"4607_CR70","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.chom.2021.04.015","volume":"29","author":"K Vanshylla","year":"2021","unstructured":"Vanshylla K, Di Cristanziano V, Kleipass F, Dewald F, Schommers P, Gieselmann L, et al. Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans. Cell Host Microbe. 2021;29:917-929.e4. https:\/\/doi.org\/10.1016\/j.chom.2021.04.015.","journal-title":"Cell Host Microbe"},{"key":"4607_CR71","doi-asserted-by":"publisher","unstructured":"Markmann AJ, Giallourou N, Bhowmik RD, Hou YJ, Lerner A, Martinez DR, et al. Sex disparities and neutralizing-antibody durability to SARS-CoV-2 infection in convalescent individuals. mSphere. 2021;6:https:\/\/doi.org\/10.1128\/msphere.00275-21.","DOI":"10.1128\/msphere.00275-21"},{"key":"4607_CR72","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/imm.13551","volume":"167","author":"C Doba\u00f1o","year":"2022","unstructured":"Doba\u00f1o C, Ram\u00edrez-Morros A, Alonso S, Ruiz-Olalla G, Rubio R, Vidal M, et al. Eleven-month longitudinal study of antibodies in SARS-CoV-2 exposed and na\u00efve primary health care workers upon COVID-19 vaccination. Immunology. 2022;167:528\u201343. https:\/\/doi.org\/10.1111\/imm.13551.","journal-title":"Immunology"},{"key":"4607_CR73","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1038\/s41467-020-17318-x","volume":"11","author":"AL Garcia-Basteiro","year":"2020","unstructured":"Garcia-Basteiro AL, Moncunill G, Tortajada M, Vidal M, Guinovart C, Jim\u00e9nez A, et al. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital. Nat Commun. 2020;11:3500. https:\/\/doi.org\/10.1038\/s41467-020-17318-x.","journal-title":"Nat Commun"},{"key":"4607_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abi8452","volume":"13","author":"C Fenwick","year":"2021","unstructured":"Fenwick C, Turelli P, Pellaton C, Farina A, Campos J, Raclot C, et al. A high-throughput cell-and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma. Sci Transl Med. 2021;13:8452. https:\/\/doi.org\/10.1126\/scitranslmed.abi8452.","journal-title":"Sci Transl Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04607-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04607-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04607-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:51:21Z","timestamp":1769169081000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-025-04607-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4607"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04607-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7546523\/v1","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by: The WHO COVID ERC (CERC.0004), the National Ethics Review Committee of DRC (HHS:1ORG0008558\/IRB, FWA:00026293), the National Ethics Review Committee of Ethiopia (02\/25\/33\/64), the IRB Bahir Dar (527\/2022) and the IRB Gondar (VP\/RTT\/05\/904\/2022) from Ethiopia, the Ghana Health Service Ethical Review Committee (GHS-ERC 015\/06\/20), the National Mozambican Ethics Review Committee (756\/CNBS\/20), the Hospital Cl\u00ednic of Barcelona Ethics Review Committee (HCB\/2021\/0507), the institutional review board of the Institute of Tropical Medicine of Antwerp (1413\/20) and the Ethics Committee of University Hospital of Antwerp (20\/26\/351). Written informed consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}